Table 3 Demographic and clinical data concerning patients with first-episode SZ, BD, MDD and for HC.
Characteristics | SZ (n = 41) | BD (n = 33) | MDD (n = 35) | HC (n = 38) | F/χ2 | p |
---|---|---|---|---|---|---|
Mean age (years) | 34.07 ± 6.87 | 34.03 ± 9.64 | 35.00 ± 7.99 | 34.5 ± 7.78 | 0.11 | 0.953 |
Education time (years) | 15.60 ± 1.65 | 15.55 ± 1.70 | 16.23 ± 1.22 | 15.77 ± 2.39 | 1.05 | 0.373 |
Sex, male/female | 14/27 | 13/20 | 12/23 | 16/22 | 0.75 | 0.862 |
Handedness, right/left | 41/0 | 33/0 | 35/0 | 38/0 | – | |
PANSS total score | 51.93 ± 25.64 | 48.76 ± 8.80 | – | – | ||
Positive score | 15.10 ± 6.84 | 11.30 ± 4.97 | – | – | ||
Negative score | 12.07 ± 7.11 | 10.09 ± 3.74 | – | – | ||
General score | 27.63 ± 9.37 | 27.45 ± 5.65 | – | – | ||
Chlorpromazine equivalents32 (mg–day) | 367.37 ± 219.62 | – | – | – | – | |
YMRS | – | 8.00 ± 5.99 | – | – | – | |
HAM-A | – | – | 19.89 ± 9.09 | – | – | |
HAM-D | – | 20.67 ± 11.37 | 15.57 ± 6.13 | – |